Sandra Levy
ARTICLES BY THIS AUTHOR
- 9/23/2019
Novo Nordisk gets FDA blessing for Rybelsus
Novo Nordisk’s Rybelsus is the first GLP-1 analog treatment available in a pill for adults with Type 2 diabetes. - 9/22/2019
AAM: Seniors denied access to new, lower-priced generics
The Association for Accessible Medicines released a white paper highlighting new data on the treatment of generic medicines in Medicare Part D. - 9/22/2019
IQVIA’s Long offers pharmacy trends rundown
At NACDS Total Store Expo, IQVIA vice president of industry relations Doug Long discussed the biggest trends in pharmacy. - 9/19/2019
Xeris gets FDA OK for Gvoke
Gvoke injection is used for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes. - 9/19/2019
Pharmacy students enter world with clinical opportunities
Where do pharmacy students fit in as they plan careers in a pharmacy landscape that has more than its fair share of challenges, as well as future opportunities? - 9/17/2019
Lupin gets FDA green light for generic Edecrin
Edecrin tablets had a market value of approximately $24 million, according to IQVIA June 2019 data. - 9/17/2019
PhRMA names Lori Reilly COO
Lori Reilly will lead federal, state and international advocacy and alliance development for the Pharmaceutical Research and Manufacturers of America. - 9/17/2019
Sanofi, Abbott partner to help patients manage diabetes
Sanofi and Abbott are collaborating to provide a connected device experience for millions of people living with diabetes and using insulin.
